Cargando…
IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis
BACKGROUND: Fosfomycin has the potential to be re-purposed as part of a combination therapy to treat neonatal sepsis where resistance to current standard of care (SOC) is common. Limited data exist on neonatal fosfomycin pharmacokinetics and estimates of bioavailability and CSF/plasma ratio in this...
Autores principales: | Kane, Zoe, Gastine, Silke, Obiero, Christina, Williams, Phoebe, Murunga, Sheila, Thitiri, Johnstone, Ellis, Sally, Correia, Erika, Nyaoke, Borna, Kipper, Karin, van den Anker, John, Sharland, Mike, Berkley, James A, Standing, Joseph F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212774/ https://www.ncbi.nlm.nih.gov/pubmed/33855449 http://dx.doi.org/10.1093/jac/dkab083 |
Ejemplares similares
-
Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overload
por: Obiero, Christina W, et al.
Publicado: (2022) -
Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis
por: Gastine, Silke, et al.
Publicado: (2021) -
Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines
por: Clements, Michelle N., et al.
Publicado: (2021) -
Variation in Target Attainment of Beta‐Lactam Antibiotic Dosing Between International Pediatric Formularies
por: Gastine, Silke, et al.
Publicado: (2021) -
2412. Our Experience With IV Fosfomycin
por: Savaj, Pratik, et al.
Publicado: (2018)